Immunome, Inc., a biotechnology company, engages in the discovery, design, development, manufacturing, and commercialization of antibody-drug conjugates and other oncology therapeutics in the United States. The company develops clinical ass...
Q1 2026
May 12, 2026
FY 2025
Mar 3, 2026
Q4 2025
Q3 2025
Nov 6, 2025
Q2 2025
Aug 6, 2025